Procter & Gamble Stock - Analyst consensus and valuation picture

Edited by ad hoc news Long-Term & Business-Model Desk. Verified prior to publication on 06/20/2026, 16:29 CET. Details in the imprint.

Procter & Gamble (US7427181091) remains a core defensive name in global equity portfolios. With no fresh company news from major wires this weekend, this Saturday update focuses on the current analyst consensus, valuation backdrop and business model.

How analysts currently rate PG

Across major data providers, Wall Street's stance on Procter & Gamble is broadly constructive. One real-time snapshot shows an overall Buy rating with an average target price around $163.61 for the stock.

This implies moderate upside against the latest available close near $150.38 on the New York Stock Exchange. The same dataset cites a trailing price-to-earnings ratio just above 21 based on recent earnings per share.

Valuation, yield and earnings backdrop

On valuation, Procter & Gamble trades at roughly 21-22 times trailing earnings, in line with or slightly above several consumer staples peers. For a company of this size, that multiple reflects the market's view of its resilient cash flows.

The group remains a consistent dividend payer and dividend grower, although the exact forward yield fluctuates with the share price. Against this backdrop, many investors use PG as a defensive anchor in diversified equity portfolios.

The business behind the stock

Procter & Gamble generates its revenue from a broad portfolio of everyday consumer brands across categories such as fabric and home care, baby and feminine care, beauty, grooming and healthcare. Well-known names include Tide, Ariel, Pampers, Gillette and Oral-B.

Where the stock trades today

Procter & Gamble stock (US7427181091) last closed at $150.38 on the New York Stock Exchange on 06/18/2026, according to delayed market data.

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.